Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation

Fei Xu(Sun Yat-sen University), Tao Peng(Chengdu Military General Hospital)

Frontiers in Molecular Biosciences

April 22, 2021

10.3389/fmolb.2021.645365

Cited by 29

Related Papers

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment

|JAMA|2020|229

Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210

|Cellular Oncology|2019|195

CytoTalk: De novo construction of signal transduction networks using single-cell transcriptomic data

|Science Advances|2021|144

MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer

|Cancer Science|2020|105

The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma

|International Journal of Oncology|2019|45